DK2242479T3 - Modtryksfiltrering af proteiner - Google Patents

Modtryksfiltrering af proteiner

Info

Publication number
DK2242479T3
DK2242479T3 DK08867937.8T DK08867937T DK2242479T3 DK 2242479 T3 DK2242479 T3 DK 2242479T3 DK 08867937 T DK08867937 T DK 08867937T DK 2242479 T3 DK2242479 T3 DK 2242479T3
Authority
DK
Denmark
Prior art keywords
counterpressure
proteins
filtration
counterpressure filtration
Prior art date
Application number
DK08867937.8T
Other languages
Danish (da)
English (en)
Inventor
Nebojsa Nikolic
Wolfgang Grabmayer
Thomas Jancik
Matthias Fried
Klaus Tschetschkowitsch
Kurt Schnecker
Alma Kasapovic
Michaela Frey
Barbara Riegler
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40602549&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2242479(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Application granted granted Critical
Publication of DK2242479T3 publication Critical patent/DK2242479T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK08867937.8T 2007-12-28 2008-12-22 Modtryksfiltrering af proteiner DK2242479T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1741807P 2007-12-28 2007-12-28
PCT/US2008/088005 WO2009086296A2 (en) 2007-12-28 2008-12-22 Counter-pressure filtration of proteins

Publications (1)

Publication Number Publication Date
DK2242479T3 true DK2242479T3 (da) 2012-01-02

Family

ID=40602549

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08867937.8T DK2242479T3 (da) 2007-12-28 2008-12-22 Modtryksfiltrering af proteiner

Country Status (18)

Country Link
US (4) US7959809B2 (enExample)
EP (2) EP2242479B1 (enExample)
JP (4) JP5027310B2 (enExample)
KR (3) KR101839278B1 (enExample)
CN (1) CN101909599B (enExample)
AR (2) AR070061A1 (enExample)
AT (1) ATE525062T1 (enExample)
AU (1) AU2008345218B2 (enExample)
CA (1) CA2709781C (enExample)
DK (1) DK2242479T3 (enExample)
ES (1) ES2377038T3 (enExample)
HR (1) HRP20110927T1 (enExample)
NZ (2) NZ600053A (enExample)
PL (1) PL2242479T3 (enExample)
PT (1) PT2242479E (enExample)
SG (1) SG187411A1 (enExample)
SI (1) SI2242479T1 (enExample)
WO (1) WO2009086296A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2377038T3 (es) * 2007-12-28 2012-03-21 Baxter International Inc. Filtración de proteínas a contra-presión
TWI469992B (zh) 2008-08-28 2015-01-21 Baxter Int 濃縮剪切靈敏生物聚合物的方法
US10100594B2 (en) * 2013-06-27 2018-10-16 Ge Oil & Gas Uk Limited Control system and a method for monitoring a filter in an underwater hydrocarbon well
WO2015107214A1 (en) * 2014-01-20 2015-07-23 Eveon Process for reconstitution of a solid form of a pharmaceutical composition

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
US5047154A (en) * 1983-03-10 1991-09-10 C.P.C. Engineering Company Method and apparatus for enhancing the flux rate of cross-flow filtration systems
SE443075B (sv) * 1984-06-01 1986-02-17 Alfa Laval Agri Int Forfarande och anordning for framstellning av mjolkkoncentrat genom membranfiltrering
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
DE3730868A1 (de) 1987-09-15 1989-03-23 Henkel Kgaa Verfahren zur abtrennung von biotechnisch hergestellten wertstoffen aus einer fermenterbruehe durch querstrom-mikro- und/oder ultrafiltration
SE9003452L (sv) 1990-10-30 1992-05-01 Teinvall Sjoeberg & Broberg Ab Saett och anordning vid vaetskefiltrering
CH687055A5 (de) * 1993-12-03 1996-09-13 Bucher Guyer Ag Masch Verfahren und Vorrichtung zum Eindicken von Fest/Fluessig-Gemischen mittels Membrantechnologie.
US5525144A (en) * 1995-04-20 1996-06-11 A/G Technology Corporation Tangential flow filtering and separating
AT403764B (de) * 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
ES2149515T3 (es) * 1996-07-10 2000-11-01 American Nat Red Cross Metodos para la separacion selectiva de componentes organicos a partir de fluidos biologicos.
US5888401A (en) * 1996-09-16 1999-03-30 Union Camp Corporation Method and apparatus for reducing membrane fouling
AT406867B (de) * 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
US5947689A (en) * 1997-05-07 1999-09-07 Scilog, Inc. Automated, quantitative, system for filtration of liquids having a pump controller
FR2772381B1 (fr) 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
US6139878A (en) 1998-04-27 2000-10-31 Aventis Behring, Llc Method for preparing a diafiltered stabilized blood product
JP4216478B2 (ja) * 1998-09-21 2009-01-28 パーダム、ハワード・イー 感温性の材料を処理する方法および装置
DE19964370B4 (de) * 1999-02-16 2006-05-11 Huss, Manfred Herstellung eines geschäumten Molkenproteinprodukts
US6623781B2 (en) 1999-07-26 2003-09-23 Cornell Research Foundation, Inc. Microfiltration of skim milk for cheese making and whey proteins
US6485762B1 (en) * 1999-07-26 2002-11-26 Cornell Research Foundation, Inc. Microfiltration of skim milk for cheese making and whey proteins
DE10211227A1 (de) * 2002-03-13 2003-10-02 Aventis Behring Gmbh Verfahren zur Rekonstitution von Iyophilisierten Proteinen
SE522048C2 (sv) 2002-05-17 2004-01-07 Hemapure Ab Anordning och system för filtrering av blod
US7439013B2 (en) * 2002-06-17 2008-10-21 Asahi Kasei Kuraray Medical Co., Ltd. Biocompatible polymer and filter for selectively eliminating leucocytes using the same
ES2214967B1 (es) 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
CA2535489C (en) * 2003-08-14 2014-09-30 D. Collen Research Foundation Vzw Antibodies against factor viii with modified glycosylation in the variable region
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
ES2317517T5 (es) * 2005-04-11 2016-01-21 Crucell Holland B.V. Purificación de virus usando ultrafiltración
ES2377038T3 (es) * 2007-12-28 2012-03-21 Baxter International Inc. Filtración de proteínas a contra-presión

Also Published As

Publication number Publication date
AU2008345218B2 (en) 2015-02-19
CN101909599B (zh) 2012-11-21
HK1150750A1 (en) 2012-01-13
KR20100106485A (ko) 2010-10-01
BRPI0821599A2 (pt) 2015-06-16
KR101748878B1 (ko) 2017-06-19
PT2242479E (pt) 2011-11-25
SG187411A1 (en) 2013-02-28
KR20170070255A (ko) 2017-06-21
US20120136139A1 (en) 2012-05-31
PL2242479T3 (pl) 2012-02-29
JP2016106131A (ja) 2016-06-16
KR20180028559A (ko) 2018-03-16
NZ600053A (en) 2013-06-28
JP5466263B2 (ja) 2014-04-09
AR116112A2 (es) 2021-03-31
EP2242479B1 (en) 2011-09-21
ES2377038T3 (es) 2012-03-21
KR101915445B1 (ko) 2018-11-05
CA2709781C (en) 2017-03-14
CN101909599A (zh) 2010-12-08
KR101839278B1 (ko) 2018-03-15
US7959809B2 (en) 2011-06-14
ATE525062T1 (de) 2011-10-15
JP5027310B2 (ja) 2012-09-19
JP2012144578A (ja) 2012-08-02
EP2242479A2 (en) 2010-10-27
CA2709781A1 (en) 2009-07-09
JP5925817B2 (ja) 2016-05-25
US20100317081A1 (en) 2010-12-16
SI2242479T1 (sl) 2012-01-31
WO2009086296A3 (en) 2009-08-27
US8075782B2 (en) 2011-12-13
NZ586316A (en) 2012-06-29
HRP20110927T1 (hr) 2012-02-29
WO2009086296A2 (en) 2009-07-09
AU2008345218A1 (en) 2009-07-09
JP2014166989A (ja) 2014-09-11
US20100314317A1 (en) 2010-12-16
US8075781B2 (en) 2011-12-13
EP2392317A1 (en) 2011-12-07
JP2011507962A (ja) 2011-03-10
US8454833B2 (en) 2013-06-04
US20090188862A1 (en) 2009-07-30
AR070061A1 (es) 2010-03-10

Similar Documents

Publication Publication Date Title
DK2126093T3 (da) Forbedring af proteinfremstilling
DK2219469T3 (da) Modificering af enzymatisk disponerede proteiner
DK3118221T3 (da) Proteiner
DK2300497T3 (da) Fremgangsmåde til oprensning af koagulationsfaktor VIII
DK2260873T3 (da) Pcylering af proteiner
BRPI0820073A2 (pt) Anticorpos anti-axl
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2061803T4 (da) Fremgangsmåde til oprensning af fc-holdige proteiner
EP2198022C0 (en) SPECIFICALLY DESIGNED ARMADILLO REPEAT PROTEINS
ATE539628T1 (de) Filter
BRPI0907819A2 (pt) filtros
DK2046826T3 (da) Exendin-fusionsproteiner
BRPI0915502A2 (pt) filtro
EP2406399A4 (en) MIRAC PROTEINS
ATE554847T1 (de) Filter
BRPI0814971A2 (pt) Proteína
DK2178900T3 (da) Oprensning af pegylerede polypeptider
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2361388T3 (da) Fremgangsmåder til karakterisering af molekyler
BRPI0811008A2 (pt) Conjunto de filtro
DK2170373T3 (da) Termostabilisering af proteiner
DK2124946T3 (da) Anvendelse af N-methylpyridiniumderivater til hepatobeskyttelse
DK2181065T3 (da) Partialoxidation af carbonhydrider
DK2213747T3 (da) Fremgangsmåde til fremstilling af membranprotein
DK2242479T3 (da) Modtryksfiltrering af proteiner